Published Studies Related to Oxsoralen Topical (Methoxsalen Topical)
Well-designed clinical trials possibly related to Oxsoralen Topical (Methoxsalen Topical)
8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis. [2006.12]
PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study. [2005.04]
Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis. [2004.05]
Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen. [2002.03]
Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. [1999.04]
Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination. [1998.05]
Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. [1997.02]
Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. [1992.10]
Plasma levels of 8-methoxypsoralen following oral or bath-water treatment. [1991.07]
A double-blind, placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. [1991.06]
5-Methoxy psoralen, etretinate, and UVA for psoriasis. [1987.12]
Other research related to Oxsoralen Topical (Methoxsalen Topical)
An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B. [2003.07]
The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion. [2003.03]
Microemulsions for topical delivery of 8-methoxsalen. [2000.10.03]
Other possibly related research studies
Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides. [2005]
Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen. [2005.09]
Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses. [2005.04]
Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. [2004.01]
An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen. [2003.07]
Skin permeation of 5-methoxypsoralen from topical dosage forms. [2003.02]
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application. [2003.03]
Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration. [2002.11]
Laser resurfacing-induced hypopigmentation: histologic alterations and repigmentation with topical photochemotherapy. [2001.06]
Cream psoralen plus ultraviolet A therapy for granuloma annulare. [2001.05]
Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches. [2001]
The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata. [2001.02]
Generalised granuloma annulare successfully treated with PUVA. [1999.11]
Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy. [1999]
Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. [1999.05]
PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. [1999.04]
PUVA therapy: current concerns in Japan. [1999.02]
An unusual cause of burn injury: unsupervised use of drugs that contain psoralens. [1999.01]
5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo. [1998.10]
Effects of antipsoriatic therapies on hepatic microsomal enzyme activity in patients with psoriasis. [1998.08.18]
Topical PUVA therapy for chronic hand eczema. [1998.05]
Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy. [1997.11]
Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. [1997.05]
[Cream PUVA photochemotherapy] [1997.02]
Comparative studies on the tolerance to photoinduced cutaneous inflammatory reactions by psoralen and rose bengal. [1997.02]
Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study). [1997.02]
Treatment with topical khellin in combination with ultraviolet A or solar-simulated radiation is carcinogenic to lightly pigmented hairless mice. [1996.10]
Foil bath PUVA in the treatment of prurigo simplex subacuta. [1996.07]
Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment. [1996.04]
Bullous pemphigoid induced by PUVA therapy. [1996]
A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema. [1995.06]
Reproducible elevation of liver transaminases by topical 8-methoxypsoralen. [1994.12]
The efficacy of localized PUVA therapy for chronic hand and foot dermatoses. [1994.11]
Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy. [1994.08]
Contact allergy to 8-methoxypsoralen. [1994.05]
Plasma levels of 8-methoxypsoralen after topical paint PUVA. [1993.03]
Evaluation of phototoxic and photogenotoxic risk associated with the use of photosensitizers in suntan preparations: application to tanning preparations containing bergamot oil. [1993]
Photoinduced cutaneous inflammatory response by psoralens. [1992.06.30]
The effects of non-interval PUVA treatment on Langerhans cells and contact hypersensitivity. [1992.03]
Phototoxicity testing in guinea-pigs. [1992.02]
Immunohistochemical study on the pattern of 50 kd cytokeratin in psoriasis. [1992.01]
Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA. [1991.01]
Citropten and bergapten suction blister fluid concentrations after solar product application in man. [1991]
Genotoxicity of bergapten and bergamot oil in Saccharomyces cerevisiae. [1990.11]
An action spectrum for the elicitation of erythema in skin persistently sensitized by photobound 8-methoxypsoralen. [1990.06]
Effect on topical 5-methoxypsoralen on tumorigenesis induced in albino and pigmented hairless mouse skin by UV irradiation. [1990.05]
The effects of bergapten and sunlight on cutaneous pigmentation. [1989.09]
Palmoplantar psoriasis: experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high-output metal halide device. [1989.06]
An action spectrum for photoinduction of prolonged cutaneous photosensitivity by topical 8-MOP. [1988.06]
Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. [1998.12]
Topical psoralen-ultraviolet A therapy for palmoplantar dermatoses: experience with 35 consecutive patients. [1998.05]
Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. [1996.11]
Effects of psoralen-UV-A-Turban in alopecia areata. [2006.03]
Phototoxicity of new psoralen-containing gels and creams versus bath PUVA. [2005.10]
Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience. [2006.02]
6-Methylangelicins: new monofunctional photochemotherapeutic agents for psoriasis. [1990.04]
[Incidence of drug-induced photosensitization during phototherapy] [2006.04]
The use of topical PUVA for palmoplantar dermatoses. [2006]
In vitro phototoxicity test using artificial skin with melanocytes. [2007.04]
Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis. [2007]
"The Laundry Bag Project"--unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. [2008.02]
Bath PUVA and psoriasis: is a milder treatment a worse treatment? [2008]
Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis. [2008.01]
Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). [2008.10]
Botanicals in dermatology: an evidence-based review. [2010]
Topical 8-methoxypsoralen increases the efficacy of narrowband ultraviolet B in psoriasis. [2009.10]
Treatment of acrodermatitis continua with topical 8-methoxypsoralen plus local narrowband ultraviolet B phototherapy. [2009.09]
Comparison of topical 8-methoxypsoralen and narrowband ultraviolet B with narrowband ultraviolet B alone in treatment-resistant sites in plaque-type psoriasis: a placebo-controlled study. [2011.12]
Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8-methoxypsoralen application. [2011.02]
Comparative efficacy of narrow-band ultraviolet B phototherapy alone and its combination with topical 8-methoxypsoralen in psoriasis. [2010.11]
Leukoderma punctata following topical PUVAsol treatment. [2010.08]
Pompholyx: a review of clinical features, differential diagnosis, and management. [2010]
Topical treatment in vitiligo and the potential uses of new drug delivery systems. [2010.05]
Comparison of topical 8-methoxypsoralen and narrowband ultraviolet B with
narrowband ultraviolet B alone in treatment-resistant sites in plaque-type
psoriasis: a placebo-controlled study. [2011]
|
